6 research outputs found
Electroneuronomiographical testing of the nictating reflex at patients with senile entropion of a lower eyelid
Purpose. Π’ΠΎ estimate parameters of the nictating reflex (NR) at patients with senile athonical enthropion a lower eyelid before and after surgical treatment Methods. 25 patients with senile athonical entropion of a lower eyelid OD of the third degree before and for 8-10 days after plastics of a lower eyelid by the deapithelious a skin-muscular rag are surveyed. Research of the NR is led on the device βN euro-M VP-4" by a standard technique with registration of the latent time of the components R1 and R2 on the party of stimulation, latent time of the component R2 on the opposite party and definition of type of the component R2 by R.A.Jakupova's classification (2002) Results. At stimulation n.supraorbitalis on the party of operation latentness of tJie component R2 ipsylaterally after operation has authentically decreased from 42,133 to 31,663 ΠΌΡ (p is less than 0,05). At stimulation n.supraorbitalis on the unoperated party also has authentically decreased latentness component R2 ipsylaterally (from 44,5 ΠΌΡ before operation to 32,575 ΠΌΡ after operation, (p is less than 0,05). It testifies to normalization of speed of carrying out of an impulse in system trigeminal-obverse nerves after surgical treatment senile athonical entropion a lower eyelid. Research of qualitative characteristics NR have shown, that after surgical treatment senile entropion of a lower eyelid OD decrease in quantity of cases hyperexitable (on 16%) types NR is observed, at ist simultaneous increase normally excitable types (on 36%). Conclusions. NR can be inportant neurophysiological the test at an estimation of a functional condition of a trunk, bayal kerners and cortical departments of the central nervous system with the purpose of optimization, of methods of surgical treatment of senile dispositions the eyelids.Π¦Π΅Π»Ρ: ΠΎΡΠ΅Π½ΠΈΡΡ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΡ ΠΌΠΈΠ³Π°ΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΡΠ»Π΅ΠΊΡΠ° (ΠΠ) Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ΅Π½ΠΈΠ»ΡΠ½ΡΠΌ Π°ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ Π·Π½ΡΡΠΎΠΏΠΈΠΎΠ½ΠΎΠΌ Π½ΠΈΠΆΠ½Π΅Π³ΠΎ Π²Π΅ΠΊΠ° Π΄ΠΎ ΠΈ ΠΏΠΎΡΠ»Π΅ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ. ΠΠ΅ΡΠΎΠ΄Ρ: ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ 25 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ΅Π½ΠΈΠ»ΡΠ½ΡΠΌ Π°ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ Π·Π½ΡΡΠΎΠΏΠΈΠΎΠ½ΠΎΠΌ Π½ΠΈΠΆΠ½Π΅Π³ΠΎ Π²Π΅ΠΊΠ° 0D 3 ΡΡΠ΅ΠΏΠ΅Π½ΠΈ Π΄ΠΎ ΠΈ Π½Π° 8-10 ΡΡΡΠΊΠΈ ΠΏΠΎΡΠ»Π΅ ΠΏΠ»Π°ΡΡΠΈΠΊΠΈ Π½ΠΈΠΆΠ½Π΅Π³ΠΎ Π²Π΅ΠΊΠ° Π΄Π΅ΡΠΏΠΈΡΠ΅Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌ ΠΊΠΎΠΆΠ½ΠΎ-ΠΌΡΡΠ΅ΡΠ½ΡΠΌ Π»ΠΎΡΠΊΡΡΠΎΠΌ. ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΠ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ Π½Π° Π°ΠΏΠΏΠ°ΡΠ°ΡΠ΅ Β«ΠΠ΅ΠΉΡΠΎ-ΠΠΠ-4Β» ΠΏΠΎ ΡΡΠ°Π½Π΄Π°ΡΡΠ½ΠΎΠΉ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊΠ΅ Ρ ΡΠ΅Π³ΠΈΡΡΡΠ°ΡΠΈΠ΅ΠΉ Π»Π°ΡΠ΅Π½ΡΠ½ΠΎΠ³ΠΎ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠΎΠ² R1 ΠΈ R2 Π½Π° ΡΡΠΎΡΠΎΠ½Π΅ ΡΡΠΈΠΌΡΠ»ΡΡΠΈΠΈ, Π»Π°ΡΠ΅Π½ΡΠ½ΠΎΠ³ΠΎ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠ° R2 Π½Π° ΠΏΡΠΎΡΠΈΠ²ΠΎΠΏΠΎΠ»ΠΎΠΆΠ½ΠΎΠΉ ΡΡΠΎΡΠΎΠ½Π΅ ΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΠΈΠΏΠ° ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠ° R2 ΠΏΠΎ ΠΊΠ»Π°ΡΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ Π . Π. Π―ΠΊΡΠΏΠΎΠ²Π° (2002). Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ: ΠΏΡΠΈ ΡΡΠΈΠΌΡΠ»ΡΡΠΈΠΈ n.supraorbitalis Π½Π° ΡΡΠΎΡΠΎΠ½Π΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ Π»Π°ΡΠ΅Π½ΡΠ½ΠΎΡΡΡ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠ° R2 ΠΈΠΏΡΠΈΠ»Π°ΡΠ΅ΡΠ°Π»ΡΠ½ΠΎ ΠΏΠΎΡΠ»Π΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΡΠΌΠ΅Π½ΡΡΠΈΠ»Π°ΡΡ- Ρ 42,133 Π΄ΠΎ 31,663 ΠΌΡ (Ρ<0,05). ΠΡΠΈ ΡΡΠΈΠΌΡΠ»ΡΡΠΈΠΈ n.supraorbitalis Π½Π° Π½Π΅ ΠΎΠΏΠ΅ΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΡΡΠΎΡΠΎΠ½Π΅ ΡΠ°ΠΊΠΆΠ΅ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΡΠΌΠ΅Π½ΡΡΠΈΠ»Π°ΡΡ Π»Π°ΡΠ΅Π½ΡΠ½ΠΎΡΡΡ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠ° R2 ΠΈΠΏΡΠΈΠ»Π°ΡΠ΅ΡΠ°Π»ΡΠ½ΠΎ (Ρ 44,5 ΠΌΡ Π΄ΠΎ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ Π΄ΠΎ 32,575 ΠΌΡ ΠΏΠΎΡΠ»Π΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ, Ρ<0.05). Π§ΡΠΎ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΠ΅Ρ ΠΎ Π½ΠΎΡΠΌΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΡΠΊΠΎΡΠΎΡΡΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΠΈΠΌΠΏΡΠ»ΡΡΠ° Π² ΡΠΈΡΡΠ΅ΠΌΠ΅ ΡΡΠΎΠΉΠ½ΠΈΡΠ½ΡΠΉ-Π»ΠΈΡΠ΅Π²ΠΎΠΉ Π½Π΅ΡΠ²Ρ ΠΏΠΎΡΠ»Π΅ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ ΡΠ΅Π½ΠΈΠ»ΡΠ½ΠΎΠ³ΠΎ Π°ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ½ΡΡΠΎΠΏΠΈΠΎΠ½Π° Π½ΠΈΠΆΠ½Π΅Π³ΠΎ Π²Π΅ΠΊΠ°. ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊ ΠΠ ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΈ, ΡΡΠΎ ΠΏΠΎΡΠ»Π΅ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ ΡΠ΅Π½ΠΈΠ»ΡΠ½ΠΎΠ³ΠΎ ΡΠ½ΡΡΠΎΠΏΠΈΠΎΠ½Π° Π½ΠΈΠΆΠ½Π΅Π³ΠΎ Π²Π΅ΠΊΠ° OD Π½Π°Π±Π»ΡΠ΄Π°Π΅ΡΡΡ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π° ΡΠ»ΡΡΠ°Π΅Π² Π³ΠΈΠΏΠ΅ΡΠ²ΠΎΠ·Π±ΡΠ΄ΠΈΠΌΡΡ
(Π½Π° 12%), Π³ΠΈΠΏΠ΅ΡΡΠΈΠ½Ρ
ΡΠΎΠ½Π½ΡΡ
(Π½Π° 8% ), Π³ΠΈΠΏΠΎΠ²ΠΎΠ·Π±ΡΠ΄ΠΈΠΌΡΡ
(Π½Π° 16%) ΡΠΈΠΏΠΎΠ² ΠΠ , ΠΏΡΠΈ ΠΎΠ΄Π½ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΌ Π²ΠΎΠ·ΡΠ°ΡΡΠ°Π½ΠΈΠΈ Π΅Π³ΠΎ Π½ΠΎΡΠΌΠΎΠ²ΠΎΠ·Π±ΡΠ΄ΠΈΠΌΡΡ
ΡΠΈΠΏΠΎΠ² (Π½Π°36%). ΠΡΠ²ΠΎΠ΄Ρ: ΠΠ ΠΌΠΎΠΆΠ΅Ρ ΡΠ²Π»ΡΡΡΡΡ Π²Π°ΠΆΠ½ΡΠΌ Π½Π΅ΠΉΡΠΎΡΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΡΠ΅ΡΡΠΎΠΌ ΠΏΡΠΈ ΠΎΡΠ΅Π½ΠΊΠ΅ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ ΡΡΠ²ΠΎΠ»Π°, Π±Π°Π·Π°Π»ΡΠ½ΡΡ
ΡΠ΄Π΅Ρ ΠΈ ΠΊΠΎΡΠΊΠΎΠ²ΡΡ
ΠΎΡΠ΄Π΅Π»ΠΎΠ² Π¦ΠΠ‘ Ρ ΡΠ΅Π»ΡΡ ΠΎΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ ΡΠ΅Π½ΠΈΠ»ΡΠ½ΡΡ
Π΄ΠΈΡΠ»ΠΎΠΊΠ°ΡΠΈΠΉ Π²Π΅ΠΊ
Inclusive meson production in peripheral collisions of ultrarelativistic heavy ions
There exist several proposals to use Weizs\"{a}cker-Williams photons
generated by ultrarelativistic heavy ions to produce exotic particles in
fusion reactions. To estimate the background conditions for such
reactions we analyze various mechanisms of meson production in very peripheral
collisions of ultrarelativistic heavy ions at RHIC and LHC energies. Besides
fusion they include also electromagnetic interactions
and strong nucleon-nucleon interactions in grazing collisions. All these
processes are characterised by low multiplicities of produced particles.
and events are simulated by corresponding Monte Carlo codes,
RELDIS and FRITIOF. In each of these processes a certain fraction of pions is
produced close to the mid-rapidity region that gives a background for the
events. The possibility of selecting mesons produced in
fusion events via different cut procedures is
demonstrated.Comment: 27 pages with 4 eps-figures included, uses axodraw.sty Tab.2 and 3
correcte
Evaluation of the effectiveness of age macular degeneration treatment
We examined 176 patients with an established diagnosis of age-related macular degeneration 'dry* form in the early and intermediate stages. The average age - 71,2 + 2,6, the average duration of the disease from the time of diagnosis of the disease 1,9 Β± 1,3 years. All patients were divided into two groups: primary - 90 people and a comparison group of 86 people. The study group consisted of patients who underwent neyroprotektional vasodilator therapy: 5 mg Retinalamin subconjunctival injection number 10 and intramuscular injections of nicotinic acid 2,0 β 10. In the comparison group performed neuroprotective and vasodilator therapy in combination simpatocorrection number 10. The result has been found most effective therapeutic strategy: simpatocorrection in combination with the following regimen: 5 mg subconjunctival injection Retinalamin number 10, and intramuscular injection of nicotinic acid, 2.0 NΒ° 10.ΠΠ°ΠΌΠΈ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΎ 176 Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Π½ΡΠΌ Π΄ΠΈΠ°Π³Π½ΠΎΠ·ΠΎΠΌ Π²ΠΎΠ·ΡΠ°ΡΡΠ½ΠΎΠΉ ΠΌΠ°ΠΊΡΠ»ΡΡΠ½ΠΎΠΉ Π΄Π΅Π³Π΅Π½Π΅ΡΠ°ΡΠΈΠΈ Β«ΡΡΡ
Π°ΡΒ» ΡΠΎΡΠΌΠ° Π² ΡΠ°Π½Π½Π΅ΠΉ ΠΈ ΠΏΡΠΎΠΌΠ΅ΠΆΡΡΠΎΡΠ½ΠΎΠΉ ΡΡΠ°Π΄ΠΈΡΡ
. Π‘ΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ-71,2 + 2,6, ΡΡΠ΅Π΄Π½ΡΡ ΠΏΡΠΎΠ΄ΠΎΠ»ΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΠΎΡ ΠΌΠΎΠΌΠ΅Π½ΡΠ° Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ 1,9+1,3 Π³ΠΎΠ΄Π°. ΠΡΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ Π±ΡΠ»ΠΈ ΡΠ°Π·Π΄Π΅Π»Π΅Π½Ρ Π½Π° Π΄Π²Π΅ Π³ΡΡΠΏΠΏΡ: ΠΎΡΠ½ΠΎΠ²Π½ΡΡ - 90 ΡΠ΅Π»ΠΎΠ²Π΅ΠΊ ΠΈ Π³ΡΡΠΏΠΏΡ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ 86 ΡΠ΅Π»ΠΎΠ²Π΅ΠΊ. Π ΠΎΡΠ½ΠΎΠ²Π½ΡΡ Π³ΡΡΠΏΠΏΡ Π²ΠΎΡΠ»ΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ, ΠΊΠΎΡΠΎΡΡΠΌ Π±ΡΠ»Π° ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Π° Π½Π΅ΠΉΡΠΎΠΏΡΠΎΡΠ΅ΠΊΡΠΎΡΠ½Π°ΡΠΈ ΡΠΎΡΡΠ΄ΠΎΡΠ°ΡΡΠΈΡΡΡΡΠ°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ: Π Π΅ΡΠΈΠ½Π°Π»Π°ΠΌΠΈΠ½ 5 ΠΌΠ³ ΡΡΠ±ΠΊΠΎΠ½ΡΡΠ½ΠΊΡΠΈΠ²Π°Π»ΡΠ½ΠΎ β10 ΠΈ Π²Π½ΡΡΡΠΈΠΌΡΡΠ΅ΡΠ½ΡΠ΅ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ Π½ΠΈΠΊΠΎΡΠΈΠ½ΠΎΠ²ΠΎΠΉ ΠΊΠΈΡΠ»ΠΎΡΡ 2,0 β10. Π Π³ΡΡΠΏΠΏΠ΅ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»Π°ΡΡ Π½Π΅ΠΉΡΠΎΠΏΡΠΎΡΠ΅ΠΊΡΠΎΡΠ½Π°Ρ ΠΈ ΡΠΎΡΡΠ΄ΠΎΡΠ°ΡΡΠΈΡΡΡΡΠ°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ Π² ΡΠΎΡΠ΅ΡΠ°Π½ΠΈΠΈ ΡΠΈΠΌΠΏΠ°ΡΠΎΠΊΠΎΡΡΠ΅ΠΊΡΠΈΠ΅ΠΉ β10. Π ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ Π±ΡΠ»Π° Π²ΡΡΠ²Π»Π΅Π½Π° Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½Π°Ρ ΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΡΡΠ°ΡΠ΅Π³ΠΈΡ, Π° ΠΈΠΌΠ΅Π½Π½ΠΎ, ΡΠΎΡΠ΅ΡΠ°Π½ΠΈΠ΅ ΡΠΈΠΌΠΏΠ°ΡΠΎΠΊΠΎΡΡΠ΅ΠΊΡΠΈΠΈ ΡΠΎ ΡΠ»Π΅Π΄ΡΡΡΠ΅ΠΉ ΡΡ
Π΅ΠΌΠΎΠΉ Π»Π΅ΡΠ΅Π½ΠΈΡ: Π Π΅ΡΠΈΠ½Π°Π»Π°ΠΌΠΈΠ½ 5 ΠΌΠ³ ΡΡΠ±ΠΊΠΎΠ½ΡΡΠ½ΠΊΡΠΈΠ²Π°Π»ΡΠ½ΠΎ β 10, Π²Π½ΡΡΡΠΈΠΌΡΡΠ΅ΡΠ½ΡΠ΅ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ Π½ΠΈΠΊΠΎΡΠΈΠ½ΠΎΠ²ΠΎΠΉ ΠΊΠΈΡΠ»ΠΎΡΡ 2.0 β10
The Use of Nutraceuticals in Patients with βDryβ Form of Age-Related Macular Degeneration on the Background of Accelerated Aging
The lutein-containing vitamin-mineral complex Retinorm, developed on the basis of the formula AREDS 2, with an optimal content of vitamins and minerals involved in antioxidant protection, is a potentially promising ophthalmic geroprotector.Purpose: to evaluate the effectiveness of vitamin-mineral complex βRetinormβ in patients with the dry form of AMD and accelerated pace of aging.Patients and Methods. The study involved 40 patients with a dry form of AMD (stage 2.3 according to AREDS classification) with an accelerated rate of aging (biological age of patients was measured by the method of Tokar, 1990). Gender distribution: men β 15 (37.5 %), women β 25 (62.5 %). The mean age of patients was 67.3 Β± 6.8 years. Patients were divided into 2 groups. Patients of the study group (n = 20) were assigned βRetinormβ 1 capsule 3 times a day for 16 weeks. Patients of the control group (n = 20) were treated with βLutein Forteβ 1 capsule 2 times a day for 16 weeks. Visometry, perimetry, optical coherence tomography of the macular zone, measurement of biological age at the beginning of the study, at 2 and 4 months of the study, the tolerability of treatment in patients with a dry form of age β related macular degeneration on the background of taking dietary supplements-vitamin and mineral complexes with lutein and zeaxanthin.Results and discussion. As a result of treatment, there were the positive dynamics in terms of visometry and perimetry in the main and control groups. There were no negative dynamics of the indicators of thickness of the retina (in the area of the fovea), and increased macular volume in the main group. In the control group there was a weak tendency to the growth of these indicators. We found a significant positive effect of Retinol on the biological age of patients to 4 months of therapy. It allows to consider the drug as a promising ophthalmoscopy an agent. The results of the study showed the effectiveness of the inclusion of βRetinormβ in patients with the dry form of AMD. The proven geroprotective effect of βRetinormβ with good tolerability of treatment and the absence of side effects from all organ systems with a long term of administration allows us to recommend it for wide use in patients with a dry form of age-related macular degeneration, including patients with an accelerated rate of aging
Involutional entropion of the inferior eyelid and the ways of its correction
Π¦Π΅Π»ΡΡ Π΄Π°Π½Π½ΠΎΠΉ ΡΠ°Π±ΠΎΡΡ ΡΠ²Π»ΡΠ΅ΡΡΡ Π°Π½Π°Π»ΠΈΠ· Π½Π°ΡΠ΅Π³ΠΎ ΠΎΠΏΡΡΠ° Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ ΡΠ΅Π½ΠΈΠ»ΡΠ½ΡΡ
ΡΠ½ΡΡΠΎΠΏΠΈΠΎΠ½ΠΎΠ² Π½ΠΈΠΆΠ½Π΅Π³ΠΎ Π²Π΅ΠΊΠ°